These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 8507760)

  • 21. [Fungal infections in transplantation patients].
    Colomba C; Antinori S
    Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal complications in organ transplant recipients.
    Halpert RD; Goodman P; Caroline DF
    Radiol Clin North Am; 1993 Nov; 31(6):1345-57. PubMed ID: 8210354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive fungal infections following liver transplantation - risk factors, incidence and outcome.
    Pacholczyk M; Lagiewska B; Lisik W; Wasiak D; Chmura A
    Ann Transplant; 2011; 16(3):14-6. PubMed ID: 21959504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence of fungal infections in pancreas transplant recipients in the absence of systemic antifungal prophylaxis.
    Shaikh SA; Zimmerman A; Nolan A; Cooper M; Abrams PL
    Clin Transplant; 2019 Oct; 33(10):e13691. PubMed ID: 31400149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prophylaxis against fungal infections in solid organ and hematopoietic stem cells transplantation].
    Rabagliati R; Santolaya ME
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S11-8. PubMed ID: 23282550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population-based cohort study.
    Hosseini-Moghaddam SM; Ouédraogo A; Naylor KL; Bota SE; Husain S; Nash DM; Paterson JM
    Transpl Infect Dis; 2020 Apr; 22(2):e13250. PubMed ID: 31981389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of fungal infections in solid organ transplant patients.
    Patterson JE
    Transpl Infect Dis; 1999 Dec; 1(4):229-36. PubMed ID: 11428994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
    Miguélez M; Lumbreras C; Herrero JA; Aguado JM; del Palacio A; Colina F; Gómez R; Lizasoain M; Moreno E; Rodríguez-Noriega A
    Med Clin (Barc); 1998 Mar; 110(11):406-10. PubMed ID: 9608495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemolytic uremic syndrome in solid-organ transplant recipients.
    Singh N; Gayowski T; Marino IR
    Transpl Int; 1996; 9(1):68-75. PubMed ID: 8748414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of fracture in patients receiving solid organ transplants.
    Ramsey-Goldman R; Dunn JE; Dunlop DD; Stuart FP; Abecassis MM; Kaufman DB; Langman CB; Salinger MH; Sprague SM
    J Bone Miner Res; 1999 Mar; 14(3):456-63. PubMed ID: 10027911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.
    Anesi JA; Baddley JW
    Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension in solid organ transplants].
    Glatz N; Wuerzner G; Pruijm M; Golshayan D; Burnier M
    Rev Med Suisse; 2009 Sep; 5(216):1771-4, 1776-7. PubMed ID: 19807050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit.
    Pugliese F; Ruberto F; Cappannoli A; Perrella SM; Bruno K; Martelli S; Marcellino V; D'Alio A; Diso D; Rossi M; Corradini SG; Morabito V; Rolla M; Ferretti G; Venuta F; Berloco PB; Coloni GF; Pietropaoli P
    Transplant Proc; 2007; 39(6):2005-7. PubMed ID: 17692677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trichosporon asahii as a prospective pathogen in solid organ transplant recipients.
    Netsvyetayeva I; Swoboda-Kopeć E; Paczek L; Fiedor P; Sikora M; Jaworska-Zaremba M; Blachnio S; Luczak M
    Mycoses; 2009 May; 52(3):263-5. PubMed ID: 18705664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fungal endocarditis in transplant recipients: A systematic review.
    Ioannou P; Papakitsou I; Kofteridis DP
    Mycoses; 2020 Sep; 63(9):952-963. PubMed ID: 32557938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P;
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.